NAT01 clinical trials

Double-blind, randomised, placebo-controlled, dose-finding phase IIb trial to evaluate the efficacy, safety, and tolerability of a 12-week-treatment with Naronapride in adult participants with at least moderate idiopathic or diabetic gastroparesis

This study is testing a new medicine, Naronapride, for adults with stomach-emptying problems like gastroparesis. We want to see if it helps reduce symptoms like nausea and bloating, and if it's safe over 12 weeks.